Correlation Between Eliem Therapeutics and Enveric Biosciences
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Enveric Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Enveric Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Enveric Biosciences, you can compare the effects of market volatilities on Eliem Therapeutics and Enveric Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Enveric Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Enveric Biosciences.
Diversification Opportunities for Eliem Therapeutics and Enveric Biosciences
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Eliem and Enveric is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Enveric Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enveric Biosciences and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Enveric Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enveric Biosciences has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Enveric Biosciences go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Enveric Biosciences
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 0.7 times more return on investment than Enveric Biosciences. However, Eliem Therapeutics is 1.43 times less risky than Enveric Biosciences. It trades about 0.04 of its potential returns per unit of risk. Enveric Biosciences is currently generating about -0.01 per unit of risk. If you would invest 251.00 in Eliem Therapeutics on August 26, 2024 and sell it today you would earn a total of 49.00 from holding Eliem Therapeutics or generate 19.52% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Eliem Therapeutics vs. Enveric Biosciences
Performance |
| Timeline |
| Eliem Therapeutics |
| Enveric Biosciences |
Eliem Therapeutics and Enveric Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Enveric Biosciences
The main advantage of trading using opposite Eliem Therapeutics and Enveric Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Enveric Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enveric Biosciences will offset losses from the drop in Enveric Biosciences' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Enveric Biosciences vs. Ocean Biomedical | Enveric Biosciences vs. Hepion Pharmaceuticals | Enveric Biosciences vs. Elevation Oncology | Enveric Biosciences vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |